1404457-07-3 Usage
Description
(S)-tert-butyl (3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)carbamate is a synthetic chemical compound characterized by its complex structure, belonging to the carbamate class of compounds. It features a tert-butyl group attached to a cyclopentyl ring, along with a cyclopropylamino group and an oxopropan-2-yl group. (S)-tert-butyl (3-cyclopentyl-1-(cyclopropylaMino)-1-oxopropan-2-yl)carbaMate's structural complexity and potential reactivity suggest it may have applications in various industries, particularly pharmaceutical and agrochemical, although further research is required to determine its specific uses and properties.
Uses
Used in Pharmaceutical Industry:
(S)-tert-butyl (3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)carbamate is used as a potential candidate for drug development due to its complex structure and possible reactivity. Its application in this industry is based on the need for novel compounds with unique properties that can be utilized in the creation of new medications.
Used in Agrochemical Industry:
In the agrochemical industry, (S)-tert-butyl (3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)carbamate is used as a potential compound for the development of new pesticides or herbicides. Its application is driven by the continuous search for innovative and effective solutions to control pests and weeds in agriculture, which can contribute to increased crop yields and reduced environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 1404457-07-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,4,4,5 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1404457-07:
(9*1)+(8*4)+(7*0)+(6*4)+(5*4)+(4*5)+(3*7)+(2*0)+(1*7)=133
133 % 10 = 3
So 1404457-07-3 is a valid CAS Registry Number.
1404457-07-3Relevant articles and documents
NOVEL COMPOUNDS AS WIP1 INHIBITORS
-
Page/Page column 78; 79, (2012/11/13)
This invention relates to the use of acylated alanine derivatives for the modulation, notably the inhibition of the activity of WIP1. Suitably, the present invention relates to the use of acylated alanine derivatives in the treatment of cancer.
